The Economic Impact of Blindness in Europe

Ophthalmic Epidemiology

Volumn 24, Issue 4, 2017, Pages 239-247

  Chakravarthy, Usha ^a   Biundo, Eliana ^b   Saka, Rasit Omer ^b   Fasser, Christina ^c   Bourne, Rupert ^d   Little, Julie Anne ^e  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Deloitte   (Belgium)

^c Retina International   (Switzerland)

^d ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Blindness; direct costs; productivity loss; visual impairment

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRIA; BELGIUM; BLINDNESS; BULGARIA; COST OF ILLNESS; CROATIA; CYPRUS; CZECH REPUBLIC; DENMARK; ESTONIA; FINLAND; FRANCE; GERMANY; GREECE; GROSS NATIONAL INCOME; GROSS NATIONAL PRODUCT; HUMAN; HUNGARY; IRELAND; ITALY; LATVIA; LITHUANIA; LUXEMBOURG; MAJOR CLINICAL STUDY; MALTA; NETHERLANDS; POLAND; PORTUGAL; PRIORITY JOURNAL; PRODUCTIVITY; PURCHASING; ROMANIA; SLOVAKIA; SLOVENIA; SPAIN; SWEDEN; UNITED KINGDOM; VISUAL IMPAIRMENT; CLINICAL TRIAL; ECONOMIC MODEL; ECONOMICS; EUROPE; FEMALE; HEALTH CARE COST; MALE; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; STATISTICS AND NUMERICAL DATA; VISUALLY IMPAIRED PERSON;

AGED; BLINDNESS; COST OF ILLNESS; EUROPE; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; PREVALENCE; VISUALLY IMPAIRED PERSONS;

EID: 85021658185     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286586.2017.1281426     Document Type: Article

References (23)

1. Ramrattan RS, Wolfs RC, Panda-Jones, et al. Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning; the Rotterdam study. Arch Ophthalmol 2001;119:1788–1794.
2. Hong T, Mitchell P, Burlutsky G, et al. Visual impairment and the incidence of falls and fractures among older people; longitudinal findings from the Blue Mountains Eye study. Invest Ophthalmol Vis Sci 2014;55:7589–7593.
3. Medeiros FA, Gracitelli CP, Boer ER, et al. Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. Ophthalmology 2015;122:293–301.
4. Bourne RA, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990–2010:a systematic analysis. Lancet 2013;1:339–349.
5. Prince MJ, Wu F, Yanfei G, et al. The burden of disease in older people and implications on health policy and practice. Lancet 2015;385:549–562
6. Frick KD, Kymes SM, Lee PP, et al., on behalf of The Vancouver Economic Burden of Vision Loss Group. The cost of visual impairment:purposes, perspectives, and guidance. Invest Ophthalmol Vis Sci 2010;51:1801–1805.
7. Köberlein J, Beifus K, Schaffert C, et al. The economic burden of visual impairment and blindness:a systematic review. BMJ Open 2013;3:e003471.
8. Eckert KA, Carter MJ, Lansingh VC, et al. A simple method for estimating the economic cost of productivity loss due to blindness and moderate to severe visual impairment. Ophthalmic Epidemiol 2015;22:349–355.
9. Smith TST, Frick KD, Holden BA, et al. Potential lost productivity resulting from the global burden of uncorrected refractive error. Bull World Health Organ 2009;87:431–437.
10. Bourne RRA, Jonas JB, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe:1990–2010. Br J Ophthalmol 2014;98:629–638.
11. RNIB website (2016). Retrieved from:www.rnib.org.uk/knowledge-and-research-hub/key-information-and-statistics
12. U.S. disability statistics (2016). Retrieved from:www.disabilitystatistics.org/reports/acs.cfm?statistic=2
13. Stevens GA, White RA, Flaxman SR, et al., on behalf of the Vision Loss Expert Group. Global prevalence of vision impairment and blindness:magnitude and temporal trends, 1990–2010. Ophthalmology 2013;120:2377–2384
14. Global vision database (2016). Retrieved from:www.globalvisiondata.org
15. Nord E., Disability weights in the Global Burden of Disease 2010:unclear meaning and overstatement of international agreement. Health Policy 2013;111:99–104.
16. Taylor HR, Jonas JB, Keeffe J, et al. Disability weights for vision disorders in Global Burden of Disease study. Lancet 2013;381(9860):23.
17. WHO methods and data sources for Global Burden of Disease estimates 2000–2011. Available from:http://www.who.int/healthinfo/statistics/GlobalDALYmethods_2000_2011.pdf
18. Meads C, Hyde C., What is the cost of blindness? Br J Ophthalmol 2003;87:1201–1204.
19. Roberts CB, Hiratsuka Y, Yamada M, et al. Economic cost of visual impairment in Japan. Arch Ophthalmol 2010;128:766–771.
20. Cruess AF, Gordon KD, Bellan L, et al. The cost of vision loss in Canada. 2. Results. Can J Ophthalmol 2011;46:315–318.
21. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 2006;124:1754–1760. Erratum in:Arch Ophthalmol 2007;125:1304.
22. Eurostat database. Accessed 8 August 2016 from:http://ec.europa.eu/eurostat/data/database
23. Jönsson B. Revealing the cost of type II diabetes in Europe. Diabetologia 2002;45:S5–12.